HE4 in the differential diagnosis of ovarian masses
- PMID: 25892674
- DOI: 10.1016/j.cca.2015.03.047
HE4 in the differential diagnosis of ovarian masses
Abstract
Ovarian masses, a common finding among pre- and post-menopausal women, can be benign or malignant. Ovarian cancer is the leading cause of death from gynecologic malignancy among women living in industrialized countries. According to the current guidelines, measurement of CA125 tumor marker remains the gold standard in the management of ovarian cancer. Recently, HE4 has been proposed as emerging biomarker in the differential diagnosis of adnexal masses and in the early diagnosis of ovarian cancer. Discrimination of benign and malignant ovarian tumors is very important for correct patient referral to institutions specialized in care and management of ovarian cancer. Tumor markers CA125 and HE4 are currently incorporated into the "Risk of Ovarian Malignancy Algorithm" (ROMA) with menopausal status for discerning malignant from benign pelvic masses. The availability of a good biomarker such as HE4, closely associated with the differential and early diagnosis of ovarian cancer, could reduce medical costs related to more expensive diagnostic procedures. Finally, it is important to note that HE4 identifies platinum non-responders thus enabling a switch to second line chemotherapy and improved survival.
Keywords: CA125; Epithelial ovarian cancer; HE4; Ovarian mass; ROMA; Tumor markers.
Copyright © 2015. Published by Elsevier B.V.
Similar articles
-
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.Gynecol Oncol. 2016 May;141(2):303-311. doi: 10.1016/j.ygyno.2016.01.016. Epub 2016 Jan 19. Gynecol Oncol. 2016. PMID: 26801941 Clinical Trial.
-
Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.Gynecol Oncol. 2012 Nov;127(2):379-83. doi: 10.1016/j.ygyno.2012.07.106. Epub 2012 Jul 24. Gynecol Oncol. 2012. PMID: 22835718 Clinical Trial.
-
Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome.Gynecol Oncol. 2013 Feb;128(2):233-8. doi: 10.1016/j.ygyno.2012.11.026. Epub 2012 Nov 28. Gynecol Oncol. 2013. PMID: 23200911
-
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas.Oncology (Williston Park). 2013 Jun;27(6):548-56. Oncology (Williston Park). 2013. PMID: 23909069 Free PMC article. Review.
-
[Ovarian tumor markers of presumed benign ovarian tumors].J Gynecol Obstet Biol Reprod (Paris). 2013 Dec;42(8):752-9. doi: 10.1016/j.jgyn.2013.09.030. Epub 2013 Nov 7. J Gynecol Obstet Biol Reprod (Paris). 2013. PMID: 24210243 Review. French.
Cited by
-
A Multiple-Array SPRi Biosensor as a Tool for Detection of Gynecological-Oncological Diseases.Biosensors (Basel). 2023 Feb 16;13(2):279. doi: 10.3390/bios13020279. Biosensors (Basel). 2023. PMID: 36832045 Free PMC article.
-
Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.J Ovarian Res. 2022 Jan 22;15(1):13. doi: 10.1186/s13048-021-00920-y. J Ovarian Res. 2022. PMID: 35062992 Free PMC article.
-
Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Expert Rev Mol Diagn. 2016 Aug;16(8):811-26. doi: 10.1080/14737159.2016.1194758. Epub 2016 Jun 23. Expert Rev Mol Diagn. 2016. PMID: 27268121 Free PMC article. Review.
-
Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Clinical Practice at a Single Hospital in Korea.Ann Lab Med. 2019 May;39(3):252-262. doi: 10.3343/alm.2019.39.3.252. Ann Lab Med. 2019. PMID: 30623617 Free PMC article.
-
Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review.BMC Womens Health. 2024 May 4;24(1):274. doi: 10.1186/s12905-024-03117-9. BMC Womens Health. 2024. PMID: 38704534 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
